These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16967323)

  • 1. Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.
    Ye SW; Wang Y; Valmori D; Ayyoub M; Han Y; Xu XL; Zhao AL; Qu L; Gnjatic S; Ritter G; Old LJ; Gu J
    J Clin Immunol; 2006 Sep; 26(5):447-56. PubMed ID: 16967323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
    Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
    J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
    Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
    Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
    Tomiyama H; Matsuda T; Takiguchi M
    J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
    Kobayashi N; Takata H; Yokota S; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
    Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
    J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties.
    Tilburgs T; Schonkeren D; Eikmans M; Nagtzaam NM; Datema G; Swings GM; Prins F; van Lith JM; van der Mast BJ; Roelen DL; Scherjon SA; Claas FH
    J Immunol; 2010 Oct; 185(7):4470-7. PubMed ID: 20817873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
    Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
    Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.
    Tomiyama H; Takata H; Matsuda T; Takiguchi M
    Eur J Immunol; 2004 Apr; 34(4):999-1010. PubMed ID: 15048710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
    Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.
    Neeson P; Shin A; Tainton KM; Guru P; Prince HM; Harrison SJ; Peinert S; Smyth MJ; Trapani JA; Kershaw MH; Darcy PK; Ritchie DS
    Gene Ther; 2010 Sep; 17(9):1105-16. PubMed ID: 20428216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation.
    Viallard JF; Blanco P; André M; Etienne G; Liferman F; Neau D; Vidal E; Moreau JF; Pellegrin JL
    Clin Immunol; 2006 Apr; 119(1):51-8. PubMed ID: 16413828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells.
    Pedroza-Seres M; Linares M; Voorduin S; Enrique RR; Lascurain R; Garfias Y; Jimenez-Martinez MC
    Br J Ophthalmol; 2007 Oct; 91(10):1393-8. PubMed ID: 17475702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
    Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.